In 2023 alone, obesity-related disability costs reached approximately $31.1 billion, while workers compensation programs absorbed an additional $5.2 billion in related expenses.[54] These outcomes impose a substantial burden on employers through increased insurance premiums, reduced productivity, and greater employee turnoverunderscoring the broader economic stakes of the obesity epidemic in the workplace
Combination approaches that pair GSH depletion with ferroptosis induction, immunotherapy, or chemotherapy may help overcome resistance, while standardized manufacturing and rigorous toxicity evaluation will be critical for regulatory approval
Number two is to use their favorite shows, songs, and characters
Coverage for the OSA indication, which the FDA approved in late 2024, remains uneven
This absorption route has precedent
Table 15